Cargando…

Variations of Clinical Target Volume Delineation for Primary Site of Nasopharyngeal Cancer Among Five Centers in China

PURPOSE: The purpose of this study is to investigate the current status of clinical target volume (CTV) delineation for primary site of nasopharyngeal cancer (NPC) among five large tertiary cancer centers in China. MATERIALS AND METHODS: The simulation CT and MR images of a patient with T3N2M0 NPC w...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Shichuan, Yang, Shuang, Xu, Peng, Xu, Yun, Zhou, Guanqun, Ou, Xiaomin, Wu, Runye, Lan, Mei, Fontanarosa, Davide, Dowling, Jason, Wang, Xiaoshen, Lin, Shaojun, Yi, Jun-Lin, Sun, Ying, Hu, Chaosu, Lang, Jinyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7468394/
https://www.ncbi.nlm.nih.gov/pubmed/32974193
http://dx.doi.org/10.3389/fonc.2020.01572
_version_ 1783578207804456960
author Zhang, Shichuan
Yang, Shuang
Xu, Peng
Xu, Yun
Zhou, Guanqun
Ou, Xiaomin
Wu, Runye
Lan, Mei
Fontanarosa, Davide
Dowling, Jason
Wang, Xiaoshen
Lin, Shaojun
Yi, Jun-Lin
Sun, Ying
Hu, Chaosu
Lang, Jinyi
author_facet Zhang, Shichuan
Yang, Shuang
Xu, Peng
Xu, Yun
Zhou, Guanqun
Ou, Xiaomin
Wu, Runye
Lan, Mei
Fontanarosa, Davide
Dowling, Jason
Wang, Xiaoshen
Lin, Shaojun
Yi, Jun-Lin
Sun, Ying
Hu, Chaosu
Lang, Jinyi
author_sort Zhang, Shichuan
collection PubMed
description PURPOSE: The purpose of this study is to investigate the current status of clinical target volume (CTV) delineation for primary site of nasopharyngeal cancer (NPC) among five large tertiary cancer centers in China. MATERIALS AND METHODS: The simulation CT and MR images of a patient with T3N2M0 NPC were sent to the centers participating. Fourteen experienced physicians contoured the targets independently, and the outlined structures were compared. The consistency and differences among these 14 CTVs are discussed. RESULTS: Two different CTV designs were used in the centers. “One-CTV” design defines one CTV with a dose of 60 Gy, whereas “two-CTV” design has a high-risk CTV with dose of 60 Gy and a medium risk CTV with dose of 54 Gy. We found that the coverage of prophylactic area is very consistent between these two designs. The variances on the coverage of some sites were also significant among physicians, including covering cavernous sinus at un-involved side, posterior space of styloid process, and caudal border on posterior pharyngeal wall. CONCLUSIONS: Standardization is the main requirement for personalization of care; our study shows that among the 14 physicians in the five centers the coverage of prophylactic areas is in excellent agreement. Two distinct strategies on CTV design are currently being used, and multiple controversies were found, suggesting further optimization of CTV for primary site of NPC is needed.
format Online
Article
Text
id pubmed-7468394
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-74683942020-09-23 Variations of Clinical Target Volume Delineation for Primary Site of Nasopharyngeal Cancer Among Five Centers in China Zhang, Shichuan Yang, Shuang Xu, Peng Xu, Yun Zhou, Guanqun Ou, Xiaomin Wu, Runye Lan, Mei Fontanarosa, Davide Dowling, Jason Wang, Xiaoshen Lin, Shaojun Yi, Jun-Lin Sun, Ying Hu, Chaosu Lang, Jinyi Front Oncol Oncology PURPOSE: The purpose of this study is to investigate the current status of clinical target volume (CTV) delineation for primary site of nasopharyngeal cancer (NPC) among five large tertiary cancer centers in China. MATERIALS AND METHODS: The simulation CT and MR images of a patient with T3N2M0 NPC were sent to the centers participating. Fourteen experienced physicians contoured the targets independently, and the outlined structures were compared. The consistency and differences among these 14 CTVs are discussed. RESULTS: Two different CTV designs were used in the centers. “One-CTV” design defines one CTV with a dose of 60 Gy, whereas “two-CTV” design has a high-risk CTV with dose of 60 Gy and a medium risk CTV with dose of 54 Gy. We found that the coverage of prophylactic area is very consistent between these two designs. The variances on the coverage of some sites were also significant among physicians, including covering cavernous sinus at un-involved side, posterior space of styloid process, and caudal border on posterior pharyngeal wall. CONCLUSIONS: Standardization is the main requirement for personalization of care; our study shows that among the 14 physicians in the five centers the coverage of prophylactic areas is in excellent agreement. Two distinct strategies on CTV design are currently being used, and multiple controversies were found, suggesting further optimization of CTV for primary site of NPC is needed. Frontiers Media S.A. 2020-08-20 /pmc/articles/PMC7468394/ /pubmed/32974193 http://dx.doi.org/10.3389/fonc.2020.01572 Text en Copyright © 2020 Zhang, Yang, Xu, Xu, Zhou, Ou, Wu, Lan, Fontanarosa, Dowling, Wang, Lin, Yi, Sun, Hu and Lang. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Zhang, Shichuan
Yang, Shuang
Xu, Peng
Xu, Yun
Zhou, Guanqun
Ou, Xiaomin
Wu, Runye
Lan, Mei
Fontanarosa, Davide
Dowling, Jason
Wang, Xiaoshen
Lin, Shaojun
Yi, Jun-Lin
Sun, Ying
Hu, Chaosu
Lang, Jinyi
Variations of Clinical Target Volume Delineation for Primary Site of Nasopharyngeal Cancer Among Five Centers in China
title Variations of Clinical Target Volume Delineation for Primary Site of Nasopharyngeal Cancer Among Five Centers in China
title_full Variations of Clinical Target Volume Delineation for Primary Site of Nasopharyngeal Cancer Among Five Centers in China
title_fullStr Variations of Clinical Target Volume Delineation for Primary Site of Nasopharyngeal Cancer Among Five Centers in China
title_full_unstemmed Variations of Clinical Target Volume Delineation for Primary Site of Nasopharyngeal Cancer Among Five Centers in China
title_short Variations of Clinical Target Volume Delineation for Primary Site of Nasopharyngeal Cancer Among Five Centers in China
title_sort variations of clinical target volume delineation for primary site of nasopharyngeal cancer among five centers in china
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7468394/
https://www.ncbi.nlm.nih.gov/pubmed/32974193
http://dx.doi.org/10.3389/fonc.2020.01572
work_keys_str_mv AT zhangshichuan variationsofclinicaltargetvolumedelineationforprimarysiteofnasopharyngealcanceramongfivecentersinchina
AT yangshuang variationsofclinicaltargetvolumedelineationforprimarysiteofnasopharyngealcanceramongfivecentersinchina
AT xupeng variationsofclinicaltargetvolumedelineationforprimarysiteofnasopharyngealcanceramongfivecentersinchina
AT xuyun variationsofclinicaltargetvolumedelineationforprimarysiteofnasopharyngealcanceramongfivecentersinchina
AT zhouguanqun variationsofclinicaltargetvolumedelineationforprimarysiteofnasopharyngealcanceramongfivecentersinchina
AT ouxiaomin variationsofclinicaltargetvolumedelineationforprimarysiteofnasopharyngealcanceramongfivecentersinchina
AT wurunye variationsofclinicaltargetvolumedelineationforprimarysiteofnasopharyngealcanceramongfivecentersinchina
AT lanmei variationsofclinicaltargetvolumedelineationforprimarysiteofnasopharyngealcanceramongfivecentersinchina
AT fontanarosadavide variationsofclinicaltargetvolumedelineationforprimarysiteofnasopharyngealcanceramongfivecentersinchina
AT dowlingjason variationsofclinicaltargetvolumedelineationforprimarysiteofnasopharyngealcanceramongfivecentersinchina
AT wangxiaoshen variationsofclinicaltargetvolumedelineationforprimarysiteofnasopharyngealcanceramongfivecentersinchina
AT linshaojun variationsofclinicaltargetvolumedelineationforprimarysiteofnasopharyngealcanceramongfivecentersinchina
AT yijunlin variationsofclinicaltargetvolumedelineationforprimarysiteofnasopharyngealcanceramongfivecentersinchina
AT sunying variationsofclinicaltargetvolumedelineationforprimarysiteofnasopharyngealcanceramongfivecentersinchina
AT huchaosu variationsofclinicaltargetvolumedelineationforprimarysiteofnasopharyngealcanceramongfivecentersinchina
AT langjinyi variationsofclinicaltargetvolumedelineationforprimarysiteofnasopharyngealcanceramongfivecentersinchina